NAS:WMGI (Netherlands) Also trade in: Delisted Germany

Wright Medical Group NV

$ 31.69 0 (0%)
Volume: 641,935 Avg Vol (1m): 1,038,220
Market Cap $: 4.00 Bil Enterprise Value $: 4.97 Bil
P/E (TTM): 0.00 P/B: 4.33
Earnings Power Value -2.92
Net Current Asset Value -8.79
Tangible Book -4.99
Projected FCF -8.8
Median P/S Value 26.28
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 4/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.14
Cash-To-Debt ranked lower than
87.27% of 330 companies
in the Medical Devices industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
WMGI: 0.14
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.14, Med: 0.35, Max: 1.53
Current: 0.14
0.14
1.53
Equity-to-Asset 0.32
Equity-to-Asset ranked lower than
90.29% of 309 companies
in the Medical Devices industry.
Industry Max: 0.99, Med: 0.63, Min: -24.4
WMGI: 0.32
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.24, Med: 0.57, Max: 0.79
Current: 0.32
0.24
0.79
Debt-to-Equity 1.24
Debt-to-Equity ranked lower than
93.18% of 220 companies
in the Medical Devices industry.
Industry Max: 11.69, Med: 0.3, Min: 0.01
WMGI: 1.24
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0.1, Med: 0.28, Max: 1.94
Current: 1.24
0.1
1.94
Debt-to-EBITDA 13.06
Debt-to-EBITDA ranked lower than
94.30% of 158 companies
in the Medical Devices industry.
Industry Max: 3384.46, Med: 1.98, Min: 0.02
WMGI: 13.06
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: -22.01, Med: -2.81, Max: 93.35
Current: 13.06
-22.01
93.35
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.60
DISTRESS
GREY
SAFE
Beneish M-Score -2.46
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -0.06%
WACC 5.8%

Profitability & Growth : 5/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -0.11
Operating Margin ranked lower than
57.69% of 312 companies
in the Medical Devices industry.
Industry Max: 1148.46, Med: 1.96, Min: -47867.72
WMGI: -0.11
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -46.57, Med: -8.95, Max: -0.11
Current: -0.11
-46.57
-0.11
Net Margin % -20.81
Net Margin ranked lower than
68.59% of 312 companies
in the Medical Devices industry.
Industry Max: 15538.12, Med: 1.4, Min: -45900
WMGI: -20.81
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -113.05, Med: -27.15, Max: -7.84
Current: -20.81
-113.05
-7.84
ROE % -22.83
ROE ranked lower than
71.38% of 304 companies
in the Medical Devices industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
WMGI: -22.83
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -64.55, Med: -28, Max: -5.19
Current: -22.83
-64.55
-5.19
ROA % -7.03
ROA ranked lower than
60.54% of 332 companies
in the Medical Devices industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
WMGI: -7.03
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -40.3, Med: -10.07, Max: -3.73
Current: -7.03
-40.3
-3.73
ROC (Joel Greenblatt) % -0.29
ROC (Joel Greenblatt) ranked lower than
57.80% of 327 companies
in the Medical Devices industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
WMGI: -0.29
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -66.87, Med: -27.4, Max: -0.29
Current: -0.29
-66.87
-0.29
3-Year Total Revenue Growth Rate 27.30
3-Year Revenue Growth Rate ranked higher than
57.09% of 254 companies
in the Medical Devices industry.
Industry Max: 300.7, Med: 4.3, Min: -100
WMGI: 5.9
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -14.9, Med: -3, Max: 10
Current: 5.9
-14.9
10
3-Year EPS w/o NRI Growth Rate 25.70
3-Year EPS w/o NRI Growth Rate ranked higher than
90.13% of 223 companies
in the Medical Devices industry.
Industry Max: 241, Med: 7.8, Min: -413
WMGI: 25.7
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: -89.2, Med: 22.65, Max: 49.1
Current: 25.7
-89.2
49.1

» WMGI's 30-Y Financials

Financials (Next Earnings Date: 2019-08-08)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:WMGI

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 339113    SIC : 3842
Compare NAS:TNDM SZSE:300529 SZSE:002223 NAS:LIVN NAS:NUVA NYSE:GMED NAS:IART HKSE:01066 NYSE:PEN XSWX:TECN TSE:6849 NYSE:ITGR NAS:PODD NAS:CNMD OCSE:OSSR TSE:8086 TSE:3360 NAS:INGN NYSE:NVRO XSWX:MOVE
Traded in other countries TRNX.Delisted T98.Germany
Address Prins Bernhardplein 200, Amsterdam, NLD, 1097 JB
Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sport medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.

Ratios

Current vs industry vs history
Forward PE Ratio 136.99
Forward P/E ranked lower than
100.00% of 52 companies
in the Medical Devices industry.
Industry Max: 454.55, Med: 25.06, Min: 3.33
WMGI: 136.99
Ranked among companies with meaningful Forward P/E only.
N/A
PB Ratio 4.33
PB Ratio ranked lower than
59.35% of 310 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 3.06, Min: 0.07
WMGI: 4.33
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 1.47, Med: 2.41, Max: 5.81
Current: 4.33
1.47
5.81
PS Ratio 4.27
PS Ratio ranked higher than
54.08% of 294 companies
in the Medical Devices industry.
Industry Max: 1136.36, Med: 3.15, Min: 0.05
WMGI: 4.27
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 2.22, Med: 3.56, Max: 5.13
Current: 4.27
2.22
5.13
EV-to-EBIT -5168.85
EV-to-EBIT ranked lower than
100.00% of 174 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
WMGI: -5168.85
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -5242.5, Med: -22.2, Max: 691
Current: -5168.85
-5242.5
691
EV-to-EBITDA 57.29
EV-to-EBITDA ranked lower than
86.17% of 188 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
WMGI: 57.29
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -304.6, Med: -16.9, Max: 640.7
Current: 57.29
-304.6
640.7
EV-to-Revenue 5.70
EV-to-Revenue ranked lower than
52.43% of 309 companies
in the Medical Devices industry.
Industry Max: 17078.6, Med: 3.73, Min: 0.05
WMGI: 5.7
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 2.3, Med: 4.3, Max: 7.2
Current: 5.7
2.3
7.2
Current Ratio 0.91
Current Ratio ranked lower than
85.80% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
WMGI: 0.91
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.91, Med: 2.43, Max: 3.29
Current: 0.91
0.91
3.29
Quick Ratio 0.70
Quick Ratio ranked lower than
82.10% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
WMGI: 0.7
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.7, Med: 1.44, Max: 1.99
Current: 0.7
0.7
1.99
Days Inventory 351.50
Days Inventory ranked lower than
87.76% of 294 companies
in the Medical Devices industry.
Industry Max: 990.33, Med: 143.61, Min: 0.63
WMGI: 351.5
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 342.93, Med: 402.04, Max: 530.83
Current: 351.5
342.93
530.83
Days Sales Outstanding 58.32
Days Sales Outstanding ranked higher than
56.16% of 276 companies
in the Medical Devices industry.
Industry Max: 907.73, Med: 69.21, Min: 0.13
WMGI: 58.32
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 58.32, Med: 69.55, Max: 118.01
Current: 58.32
58.32
118.01
Days Payable 87.58
Days Payable ranked higher than
71.65% of 261 companies
in the Medical Devices industry.
Industry Max: 912.5, Med: 58.34, Min: 1
WMGI: 87.58
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 51.36, Med: 84.7, Max: 105.89
Current: 87.58
51.36
105.89

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -3.10
3-Year Share Buyback Rate ranked lower than
81.15% of 244 companies
in the Medical Devices industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
WMGI: -3.1
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -35, Med: -18.85, Max: -3.1
Current: -3.1
-35
-3.1

Valuation & Return

Current vs industry vs history
Price-to-Median-PS-Value 1.21
Price-to-Median-PS-Value ranked higher than
68.78% of 237 companies
in the Medical Devices industry.
Industry Max: 20.13, Med: 1.02, Min: 0.02
WMGI: 1.21
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.68, Med: 1.03, Max: 1.32
Current: 1.21
0.68
1.32
Earnings Yield (Joel Greenblatt) % -0.02
Earnings Yield (Greenblatt) ranked lower than
56.02% of 332 companies
in the Medical Devices industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
WMGI: -0.02
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -17.7, Med: -4.3, Max: 0.2
Current: -0.02
-17.7
0.2

More Statistics

Revenue (TTM) (Mil) $ 867.78
EPS (TTM) $ -1.58
Beta 0.9
Volatility % 21.12
52-Week Range $ 24.1 - 32.86
Shares Outstanding (Mil) 126.12

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 4
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y